Analysis of the entire coding region of the cystic fibrosis transmembrane regulator gene in idiopathic pancreatitis
โ Scribed by Carlo Castellani; Macarena Gomez Lira; Luca Frulloni; Antonella Delmarco; Maria Marzari; Alberto Bonizzato; Giorgio Cavallini; PierFranco Pignatti; Gianni Mastella
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 34 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1059-7794
No coin nor oath required. For personal study only.
โฆ Synopsis
CF Project, law 548/93; Italian CNR Strategic Project for Biothechnology. Gomez Lira M. had a fellowship from the Cystic Fibrosis Center of Verona
Communicated by Mireille Claustres
Many Cystic Fibrosis (CF) carriers have been detected testing some subjects with chronic pancreatititis for a limited number of mutations. The aim of this study was to find out if some subjects with pancreatitis and a CFTR mutation actually carry another, undetected mutation. We screened for 18 CFTR mutations plus the CFTR intron 8 poly(T) tract length a population of 67 patients suffering from idiopathic either acute, or recurrent acute, or chronic pancreatitis. Three of them were diagnosed as affected by CF. Among the others, a subset of 14 (8 CFTR mutation carriers, 4 5T carriers, and 2 sweat chloride borderliners) was selected and analyzed by denaturing gradient gel electrophoresis. Six possibly CFrelated mutations were detected: L997F and 3878delG were found in two of the subjects already carrying another mutation, S1235R and L997F in one patient carrying the 5T, and L997F and D614G in the two patients with borderline sweat chloride. Among the 14 selected cases a total of 11 patients carried at least one mutation, and three of them were compound heterozygotes. Though it is debatable whether these three individuals can be considered affected by CF, their pancreatitis is possibly a clinical manifestation of some CFTR-related disease.
๐ SIMILAR VOLUMES
Lipoprotein lipase (LPL) catalyzes the hydrolysis of the core triacylglycerols of plasma very low density lipoproteins (VLDL) and chylomicrons . It thus controls a crucial step in the metabolism of triglycerides of exogenous and endogenous origin. Inherited LPL deficiency is clinically expressed as